receptor modulator. Can potentiate or inhibit recombinant GABAA
function depending on subunit combination. Enhances native GABAA
receptor function and is anxiolytic following systemic administration in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Enhancement of benzodiazepine and GABA binding by the novel anxiolytic, tracazolate.
Meiners and Salama
Tracazolate reveals a novel type of allosteric interaction with recombinant γ-aminobutyric acidA receptors.
Thompson et al.
Pharmacological properties of tracazolate: a new non-benzodiazepine anxiolytic agent.
Patel and Malick
The citations listed below are publications that use Tocris products. Selected citations for Tracazolate hydrochloride include:
Showing Results 1 - 1 of 1